Exercise and Physical Activity in the Therapy of Substance Use Disorders by Elisabeth Zschucke, Andreas Heinz, Andreas Ströhle

“…Exercise and physical activity are constantly gaining attention as adjuvant treatment for substance use disorders, supplementing classical pharmacological and psychotherapeutic approaches. …”
Get full text

Abstinence Self-Efficacy and Resilience in Persons with Substance Use Disorder by L. Iris Devi, Arunjyoti Baruah, Nurnahar Ahmed

Subjects: Get full text

District-level differences in the distribution of mental and substance use disorders in Assam by Vijay Gogoi, Priyadarshee Abhishek, Soumik Sengupta, Indrajeet Banerjee, Samir Sarma, H. Sobhana, Sonia P. Deuri, Kangkan Pathak, Gautham M. Sukumar, Vivek Benegal, Girish N. Rao, Mathew Varghese, Gopalkrishna Gururaj

Get full text

Corticostriatal contributions to dysregulated motivated behaviors in stress, depression, and substance use disorders by Benjamin M. Siemsen, Daniela Franco, Mary Kay Lobo

Subjects: Get full text

Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder by Nicholas C. Cardamone, Rebecca E. Stewart, Kyle M. Kampman, Steven C. Marcus

Subjects: Get full text

The Strength of a Story: Partnering With a Community Organization to Destigmatize Substance Use Disorder by Noah Sorkow, Cameron Lauf, Stephen H. Berns

Subjects: Get full text

Psychotic and Substance Use Disorders Among Relatives of Patients with Bipolar Disorder at a Hospital in Kenya by Kimutai Katwa, Benson Gakinya, Irene Chesire, Maloosoy Katwa, Nicodemus Kuboi

“…Results: The prevalences of psychotic, alcohol and substance use disorders were 23.6%, 13.6%, and 6%, respectively. …”
Get full text

Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk by Green RP, Blum K, Lewandrowski KU, Gold MS, Lewandrowski AP, Thanos PK, Dennen CA, Baron D, Elman I, Sharafshah A, Modestino EJ, Badgaiyan RD

Subjects: Get full text

Telehealth interventions for substance use disorders in low- and- middle income countries: A scoping review. by Margaret Isioma Ojeahere, Sarah Kanana Kiburi, Paul Agbo, Rakesh Kumar, Florence Jaguga

“…The increasing prevalence and magnitude of harmful effects of substance use disorders (SUDs) in low- and middle-income countries (LMICs) make it imperative to embrace interventions which are acceptable, feasible, and effective in reducing this burden. …”
Get full text

Association between Dysfunctional Beliefs and Coping Strategy among Persons Suffering from Substance Use Disorder by Prosenjit Ghosh, Saptarshi Paul Choudhury, Subho Panja

Subjects: Get full text

The effect of rehabilitation on remission following detoxification treatment in alcohol and substance use disorders: A pilot study by Mustafa Danisman, Gamze Zengin Ispir, Kubra Sezer Katar, Zehra Ucar Hasanli, Ziya Bilgin

Subjects: Get full text

Decoding substance use disorder severity from clinical notes using a large language model by Maria Mahbub, Gregory M. Dams, Sudarshan Srinivasan, Caitlin Rizy, Ioana Danciu, Jodie Trafton, Kathryn Knight

“…Abstract Substance use disorder (SUD) poses a major concern due to its detrimental effects on health and society. …”
Get full text

Using photovoice to define “community” in substance use disorder research engaging service users, providers, and policymakers by McGladrey Margaret L, Marisa Booty, Ramona Olvera, Peter Balvanz, Hilary L. Surratt, Shannon Matthews, Susannah Stitzer, Owusua Yamoah, Sylvia Ellison, Kevin Campbell, Amy Farmer, Bethany Gealy, Mike Greenwell, Felicia Harris, Amy Kuntz, Sara Szelagowski, Alexandrea Shouse, Carrie B. Oser

“…(197 words)The ideals of community-engaged health research are challenging to realize ethically and methodologically, particularly when focused on substance use disorder (SUD), in which the power differentials inherent to stigma marginalize people with lived experience (LE) as full community participants. …”
Get full text

Addressing racial and ethnic disparities in premature exits from permanent supportive housing among residents with substance use disorders by Talia J. Panadero, Sonya Gabrielian, Marissa J. Seamans, Lillian Gelberg, Jack Tsai, Taylor Harris

Subjects: Get full text

Resilience and its relationship with quality of life and comorbid substance use disorder in patients with type I bipolar disorder by Shady Mohamed Moustafa, Magda Taha Kamal Aldin, Haydy Hassan Sayed, Ahmed Elarabi Hendi

Subjects: Get full text

Use of alternative payment models for substance use disorder prevention in the United States: development of a conceptual framework by Elian Rosenfeld, Sarah Potter, Jennifer Caputo, Sushmita Shoma Ghose, Nelia Nadal, Christopher M. Jones, Margaret R. Kuklinski, Andrew D. Carlo, D. Max Crowley, Lisa Clemans-Cope, Michael T. French

Subjects: “…Substance Use Disorder Prevention…”
Get full text

The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis by Jack Wilson, Andrew Langcake, Zachary Bryant, Tom P. Freeman, Janni Leung, Gary C. K. Chan, Amir Englund, Myfanwy Graham, Emily Stockings

“…Abstract There has been a global increase in the use of cannabinoids as a treatment for mental health (MH) and substance use disorders (SUD). In 2016, an Australian government-funded review found that although medicinal cannabinoids accounted for a small reduction in MH symptoms, the results varied according to study design. …”
Get full text

Barriers to 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys by Maria Carmen Viana, Alan E. Kazdin, Meredith G. Harris, Dan J. Stein, Daniel V. Vigo, Irving Hwang, Sophie M. Manoukian, Nancy A. Sampson, Jordi Alonso, Laura Helena Andrade, Guilherme Borges, Brendan Bunting, José Miguel Caldas-de-Almeida, Giovanni de Girolamo, Peter de Jonge, Oye Gureje, Josep Maria Haro, Elie G. Karam, Viviane Kovess-Masfety, Jacek Moskalewicz, Fernando Navarro-Mateu, Daisuke Nishi, Marina Piazza, José Posada-Villa, Kate M. Scott, Cristian Vladescu, Bogdan Wojtyniak, Zahari Zarkov, Ronald C. Kessler, Timothy Kessler, World Mental Health Survey collaborators

“…We focus on the n = 5,136 respondents with 12-month DSM-IV anxiety, mood, or substance use disorders with perceived need for treatment. …”
Get full text

Pituitary adenylate cyclase-activating polypeptide plays a role in neuropsychiatric and substance use disorders: sex-specific perspective by Catherine E. Van Doorn, Mikala M. Zelows, Anel A. Jaramillo

“…Studies expand the role of PACAP to substance use disorders (SUD) by demonstrating modulation of PACAP can lead to neurobiological changes induced by nicotine, ethanol, stimulants and opioids. …”
Get full text

Comparative effects of methamphetamine, cannabis, and polysubstance use on oral health by Osman Hasan Tahsin Kılıç, Duygu Kürklü Arpaçay, Onur Çağdaş Gezen, Zehra Nur Bayram, Aysel Başer

Subjects: “…substance use disorder…”
Get full text